Furthermore, recent finding reported that GLP-1 RAs significantly reduced C-reactive protein (CRP) levels in obese IBD patients, alongside a nearly statistically significant reduction in fecal calprotectin ( 100 ).
← all excerpts
GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation.
1
—
—